Ohio State University Wexner Medical Center in Columbus reported a 25% decline in clinical support calls and incidents since 2021, according to a workplace safety update published April 2. The system defines clinical support calls as requests to security for…
Research & Analysis
The Defense Department’s “Annual Report on Suicide in the Military” reported 471 service member suicide deaths in 2024, down from 531 in 2023. Here are four things to know:
About two-thirds of mental health and substance use disorder treatment facilities, also known as “mixed” facilities, accepted older patients through Medicare, compared to 44% of SUD treatment-only facilities, creating access challenges for those who rely on the program, according to…
The share of nonphysician clinicians prescribing antipsychotics for Medicare Part D beneficiaries increased between 2013 and 2023, according to a study published March 25 in JAMA Network Open. The study was conducted by researchers from the University of Texas Health…
Triage scores for children presenting with mental or behavioral health concerns were inaccurate in two-thirds of cases, according to a recent study published in JAMA Network Open. Researchers at Ann & Robert H. Lurie Children’s Hospital of Chicago analyzed 74,564…
Advertisement
An integrated behavioral healthcare model was associated with faster improvement and higher remission rates for patients with depression, according to a research by Lone Tree, Colo.-based Family Care Center published March 19 in Psychiatry Services. The model combines medication management,…
Psychedelic-assisted therapy was no more effective than traditional antidepressants for treating major depression, according to a study published March 18 in JAMA Psychiatry. The meta-analysis reviewed 24 trials, including eight psychedelic therapy trials with 249 patients and 16 open-label antidepressant…
Young people with cannabis use disorder have higher rates of psychiatric disorder diagnosis than peers with other substance use disorders, according to a March 5 study published in The American Journal of Psychiatry. Led by researchers at Baltimore-based Johns Hopkins…
GLP-1 receptor agonists were associated with reduced risk of alcohol, cannabis, cocaine, nicotine and opioid use disorders, as well as other substance use disorders, suggesting potential prevention effects across a broad range of substances, according to a study published March…
Global warming of 1 to 6 degrees Celsius could generate up to $57 billion in annual anxiety-related costs and $47 billion tied to depression, according to a study published Feb. 20 in The Lancet Planetary Health. The study, conducted by…